MEDI5752: Novel PD-1/CTLA-4 bispecific checkpoint inhibitor for advanced solid tumors
Ben Tran • 21 Apr 2022
Kidney cancer updates: avelumab/axitinib, pembro/axitinib, bevacizumab/atezo & ipilimumab/nivo
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter